AACR NCI EORTC: Cell Therapy Post-Conference Report

Our Beacon DDR experts have screened each abstract from the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held on 11th – 15th October, to identify 47 DDR-relevant abstracts (13 clinical, 32 preclinical, 2 both) . These have been listed and summarised in our Post-Conference Report.

AACR NCI EORTC: DDR Abstract Highlights

This report sample provides a complete guide to all DDR-relevant abstracts presented at the 2023 AACR-NCI-EORTC International Conference, offering you a concise summary of each abstract as well as some additional analysis. Download your copy for free today.

You May Also Be Interested In…

Learn More About DDR

What is Beacon DDR?
  • The Most Comprehensive Way to Search the DDR Drug Development Landscape: Unique search ontologies based on DDR drug and trial characteristics
  • Market Leading Approach to DDR Preclinical & Clinical Data Curation: Manual curation of key DDR research and development data points by DDR research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search DDR company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon DDR

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

Menu
Search Icon
Close Icon
Search